RECRUITING

Quantitative Xylazine Measurement in ED

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose (OD) Patients in the Emergency Department (ED)

Official Title

Quantitative Xylazine Measurement Among Non-Fatal Opioid Overdose Patients in the Emergency Department

Quick Facts

Study Start:2025-04-01
Study Completion:2026-02-24
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06949605

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ED patient
  2. * Opioid OD (both NPS and non-NPS)
  3. * Availability of waste blood specimens for analysis
  4. * Availability of waste urine specimens for analysis
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Jonathan Berger, MPH
CONTACT
212-824-8046
jonathan.berger@mountsinai.org

Principal Investigator

Jennifer Love, MD, MS
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine

Study Locations (Sites)

NYC Health + Hospitals/Elmhurst
Elmhurst, New York, 11373
United States
Icahn School of Medicine
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Jennifer Love, MD, MS, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-01
Study Completion Date2026-02-24

Study Record Updates

Study Start Date2025-04-01
Study Completion Date2026-02-24

Terms related to this study

Keywords Provided by Researchers

  • Opioid
  • Xylazine
  • Substance Use

Additional Relevant MeSH Terms

  • Opioid Overdose
  • Substance Use Disorders